Tyramine-induced modifications of ventricular fibrillation thresholds in the dog: influence of sympatholytic agents.
D018663:Adrenergic Agents / Q000494:pharmacology; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D001949:Bretylium Compounds / Q000494:pharmacology; D004285:Dogs; D004983:Ethanolamines / Q000494:pharmacology; D006145:Guanethidine / Q000494:pharmacology; D006321:Heart / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D011433:Propranolol / Q000494:pharmacology; D012110:Reserpine / Q000494:pharmacology; D013565:Sympatholytics / Q000494:pharmacology*; D014439:Tyramine / Q000037:antagonists & inhibitors*; D014693:Ventricular Fibrillation / Q000139:chemically induced*
D018663:Adrenergic Agents; D001949:Bretylium Compounds; D004983:Ethanolamines; D013565:Sympatholytics; D012110:Reserpine; D011433:Propranolol; D014439:Tyramine; D006145:Guanethidine